A large number of previous studies have confirmed that the activation of PI3K/AKT signaling pathway can significantly reduce the inflammatory response, thus relieving myocardial ischemia‐reperfusion injury (Ke et al., 2017; Wei et al., 2021). The gene discussed is AKT1; the disease is myocardial ischemia.